AhR and Cancer: From Gene Profiling to Targeted Therapy
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that has been shown to be an essential regulator of a broad spectrum of biological activities required for maintaining the body’s vital functions. AhR also plays a critical role in tumorigenesis. Its role in cancer is com...
Main Authors: | Anaïs Paris, Nina Tardif, Marie-Dominique Galibert, Sébastien Corre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/752 |
Similar Items
-
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
by: Héloïse M. Leclair, et al.
Published: (2020-07-01) -
Epigenetic Regulations of AhR in the Aspect of Immunomodulation
by: Anna Wajda, et al.
Published: (2020-09-01) -
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
by: Marco Gargaro, et al.
Published: (2021-01-01) -
Effect of diet and intestinal AhR expression on fecal microbiome and metabolomic profiles
by: Fang Yang, et al.
Published: (2020-11-01) -
New Treatments in Renal Cancer: The AhR Ligands
by: Boris Itkin, et al.
Published: (2020-05-01)